APPLICATIONS OF TECHNOLOGY: Nuclear energy or nuclear fuel reprocessing plants Pharmaceutical isotope production Pharmaceutical companies using lanthanide or actinide drugs Chemical industry ADVANTAGES: Greater separation efficacy Robust chelators Highly versatile method Simplified process ABSTRACT: Berkeley Lab researchers Rebecca Abergel … [Read more...] about HOPO Ligands to Separate and Purify Metal Ions including Lanthanides and Actinides 2017-106
Diagnostics and Therapeutics
Selective Complexation and Separation of Tetravalent Metal Ions from Other Ions 2017-107
APPLICATIONS OF TECHNOLOGY: Nuclear energy or nuclear fuel reprocessing plants Pharmaceutical isotope production Pharmaceutical companies using lanthanide or actinide drugs Chemical industry ADVANTAGES: Highly selective Improved performance and reliability Versatile process Fewer steps ABSTRACT: Berkeley Lab researchers Rebecca Abergel and … [Read more...] about Selective Complexation and Separation of Tetravalent Metal Ions from Other Ions 2017-107
Influences on Gut Microbiome 2017-039
APPLICATIONS OF TECHNOLOGY: Probiotic supplement development Enhance behavior and immune function by modulating microbiome composition ADVANTAGES: Provides a link between host microbiome composition and memory Establishes a connection between host genetics and gut microbiome ABSTRACT: By cross referencing mouse behavior, immune function, gut microbial … [Read more...] about Influences on Gut Microbiome 2017-039
Decorporation Agent for Therapeutic Chelation of Industrial and Clinical Toxic Heavy Metals 2016-078
APPLICATIONS OF TECHNOLOGY: Treatment and prevention of gadolinium deposition in patients undergoing MRIs Treatment for exposure to toxic metals including lead, tin, and cadmium ADVANTAGES: Strong decorporation efficacy High affinity for the toxic elements gadolinium (Gd), lead (Pb), tin (Sn), and cadmium (Cd) ABSTRACT: Researchers at Berkeley Lab have … [Read more...] about Decorporation Agent for Therapeutic Chelation of Industrial and Clinical Toxic Heavy Metals 2016-078
Oral Dosage Forms for Actinide Decorporation Agent 2016-079
APPLICATIONS OF TECHNOLOGY: Treatment of radionuclide exposure Treatment or prevention of gadolinium (Gd) deposition from MRIs Treatment for exposure to toxic metals including lead (Pb), tin (Sn), and cadmium (Cd) ADVANTAGES: Administered orally in a variety of dosage forms Ease of clinical use Enables use during emergencies or mass … [Read more...] about Oral Dosage Forms for Actinide Decorporation Agent 2016-079